[ad_1]
In a statement to the AA correspondent, Çalış recalled that the vaccination studies began in March.
Stating that ERU’s Vaccine Research and Development Application Center has a very good infrastructure, Çalış said the researchers also have experience in vaccine development.
Çalış emphasized that the Kovid-19 virus was first isolated and genetically mapped by the center, and then animal experiments were completed, saying:
“As of today, we have started clinical trials, that is, we have started Phase 1 studies. We test our vaccine with one of our volunteers today. We will try another volunteer tomorrow. We will test it with one volunteer per day until a certain day. 10-15 days later, 10’10 ‘We hope to complete the Phase 1 study in 2 months. When this is done, the Phase 2 study arrives, so we will work with more volunteers. At this stage, we will administer the vaccine to 44 volunteers. Phase 2 will consist of almost 300 volunteers. The phase 2 study will be carried out by the Center for Research and Good Clinical Practices (IKUM) “.
“The volunteer is in good condition”
When mentioning the status of the volunteer who received the first dose of the vaccine, Çalış said: “The condition of our volunteer is very good at the moment. No side effects have been observed. I am receiving information hour by hour. Do they have side effects? How will your blood values be controlled? So this period lasts for 2 months. ” If they are successful in these, study 2 will pass. If you are unsuccessful in Phase 1, you will not be able to proceed to Phase 2. We hope to be successful. “He used the expressions.
The attention-grabbing national and local Erün developed vaccine works, said the completion of the 3 vaccine currently in preclinical studies in Turkey.
Çalış invited other vaccination centers to İKUM to carry out Phase 1 studies, saying: “We don’t have one, not three, but 10 Kovid-19 vaccines, nationwide, this is the important thing. I hope it is so Soon as Phase-1, Phase. -2, Phase 3 studies are complete and, as our Dear President said, it will be usable for both our nation and all of humanity in the spring. ” I speak.
“The volunteers were isolated for 5 days”
Associate Director of IKUM. Dr. Zafer Sezer said that clinical trials began after the preclinical was completed, both after approval from the ethics committee and approval from the Ministry of Health.
Explaining that the volunteers went through a selection process, Sezer gave the following information:
“Here, we isolate the volunteers for 5 days in the hotel. Meanwhile, they are physically examined, they go through various tests. They shouldn’t have caught Kovid-19 before. Afterwards, the first vaccine is given on the first day of the volunteers who have all conditions “. Meanwhile, the volunteers will be closely monitored in terms of vaccine safety and side effects. We will have obtained the first results of the Phase-1 study on day 43. If we are successful, we will proceed to the second phase. “
